Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 61

1.

Design of hypoxia-targeting radiopharmaceuticals: selective uptake of copper-64 complexes in hypoxic cells in vitro.

Dearling JL, Lewis JS, Mullen GE, Rae MT, Zweit J, Blower PJ.

Eur J Nucl Med. 1998 Jul;25(7):788-92.

PMID:
9662602
2.

Copper bis(diphosphine) complexes: radiopharmaceuticals for the detection of multi-drug resistance in tumours by PET.

Lewis JS, Dearling JL, Sosabowski JK, Zweit J, Carnochan P, Kelland LR, Coley HM, Blower PJ.

Eur J Nucl Med. 2000 Jun;27(6):638-46.

PMID:
10901449
3.

Synthesis and evaluation of copper radiopharmaceuticals with mixed bis(thiosemicarbazone) ligands.

Ackerman LJ, West DX, Mathias CJ, Green MA.

Nucl Med Biol. 1999 Jul;26(5):551-4.

PMID:
10473194
5.

Tissue blood flow estimation with copper(II)-pyruvaldehyde bis (N-4-methylthiosemicarbazone) and PET.

Young H, Carnochan P, Zweit J, Babich J, Cherry S, Ott R.

J Nucl Biol Med. 1994 Dec;38(4 Suppl 1):89-91.

PMID:
7632775
6.

Orthogonal 18F and 64Cu labelling of functionalised bis(thiosemicarbazonato) complexes.

Carroll L, Bejot R, Hueting R, King R, Bonnitcha P, Bayly S, Christlieb M, Dilworth JR, Gee AD, Declerck J, Gouverneur V.

Chem Commun (Camb). 2010 Jun 21;46(23):4052-4. doi: 10.1039/b926980k. Epub 2010 Apr 20.

PMID:
20407674
7.

High purity production and potential applications of copper-60 and copper-61.

McCarthy DW, Bass LA, Cutler PD, Shefer RE, Klinkowstein RE, Herrero P, Lewis JS, Cutler CS, Anderson CJ, Welch MJ.

Nucl Med Biol. 1999 May;26(4):351-8.

PMID:
10382836
8.

In vitro and in vivo evaluation of bifunctional bisthiosemicarbazone 64Cu-complexes for the positron emission tomography imaging of hypoxia.

Bonnitcha PD, Vāvere AL, Lewis JS, Dilworth JR.

J Med Chem. 2008 May 22;51(10):2985-91. doi: 10.1021/jm800031x. Epub 2008 Apr 17.

9.

Preclinical studies of [61Cu]ATSM as a PET radiopharmaceutical for fibrosarcoma imaging.

Jalilian AR, Rostampour N, Rowshanfarzad P, Shafaii K, Kamali-Dehghan M, Akhlaghi M.

Acta Pharm. 2009 Mar;59(1):45-55. doi: 10.2478/v10007-009-0008-9.

PMID:
19304557
11.

Human biodistribution and dosimetry of the PET perfusion agent copper-62-PTSM.

Wallhaus TR, Lacy J, Whang J, Green MA, Nickles RJ, Stone CK.

J Nucl Med. 1998 Nov;39(11):1958-64.

12.

Transfer of copper between bis(thiosemicarbazone) ligands and intracellular copper-binding proteins. insights into mechanisms of copper uptake and hypoxia selectivity.

Xiao Z, Donnelly PS, Zimmermann M, Wedd AG.

Inorg Chem. 2008 May 19;47(10):4338-47. doi: 10.1021/ic702440e. Epub 2008 Apr 16.

PMID:
18412332
13.

Noninvasive 64Cu-ATSM and PET/CT assessment of hypoxia in rat skeletal muscles and tendons during muscle contractions.

Skovgaard D, Kjaer M, Madsen J, Kjaer A.

J Nucl Med. 2009 Jun;50(6):950-8. doi: 10.2967/jnumed.109.062216. Epub 2009 May 14.

14.

Investigation into 64Cu-labeled Bis(selenosemicarbazone) and Bis(thiosemicarbazone) complexes as hypoxia imaging agents.

McQuade P, Martin KE, Castle TC, Went MJ, Blower PJ, Welch MJ, Lewis JS.

Nucl Med Biol. 2005 Feb;32(2):147-56.

PMID:
15721760
15.

Copper bis(thiosemicarbazone) complexes as hypoxia imaging agents: structure-activity relationships.

Dearling JL, Lewis JS, Mullen GE, Welch MJ, Blower PJ.

J Biol Inorg Chem. 2002 Mar;7(3):249-59. Epub 2001 Sep 8.

PMID:
11935349
16.

Basic characterization of 64Cu-ATSM as a radiotherapy agent.

Obata A, Kasamatsu S, Lewis JS, Furukawa T, Takamatsu S, Toyohara J, Asai T, Welch MJ, Adams SG, Saji H, Yonekura Y, Fujibayashi Y.

Nucl Med Biol. 2005 Jan;32(1):21-8. Erratum in: Nucl Med Biol. 2005 Jul;32(5):559.

PMID:
15691658
17.

Studies of 99mTc-BnAO (HL-91): a non-nitroaromatic compound for hypoxic cell detection.

Zhang X, Melo T, Ballinger JR, Rauth AM.

Int J Radiat Oncol Biol Phys. 1998 Nov 1;42(4):737-40.

PMID:
9845087
18.
19.

Synthesis and evaluation of two technetium-99m-labeled peptidic 2-nitroimidazoles for imaging hypoxia.

Su ZF, Zhang X, Ballinger JR, Rauth AM, Pollak A, Thornback JR.

Bioconjug Chem. 1999 Sep-Oct;10(5):897-904.

PMID:
10502359
20.

Ex vivo cell labeling with 64Cu-pyruvaldehyde-bis(N4-methylthiosemicarbazone) for imaging cell trafficking in mice with positron-emission tomography.

Adonai N, Nguyen KN, Walsh J, Iyer M, Toyokuni T, Phelps ME, McCarthy T, McCarthy DW, Gambhir SS.

Proc Natl Acad Sci U S A. 2002 Mar 5;99(5):3030-5. Epub 2002 Feb 26. Erratum in: Proc Natl Acad Sci U S A. 2006 Jul 5;103(27):10526. Adonai, Nora [corrected to Adonai, Nona].

Supplemental Content

Support Center